3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
摘要:
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调控、调节和/或抑制异常细胞增殖。
公开号:
US20030199478A1
作为产物:
描述:
4-(4-硝基苯)丁酸 、 吗啉 、 碳酸氢钠 在
乙酸乙酯 、 Sodium sulfate-III 、 crude product 、 silica gel 作用下,
以
四氢呋喃 为溶剂,
反应 17.0h,
以1-morpholin-4-yl-4-(4-nitro-phenyl)-butan-1-one is isolated as a white solid in the amount of 1.3925 gms的产率得到1-morpholin-4-yl-4-(4-nitro-phenyl)-butan-1-one
参考文献:
名称:
3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
[EN] 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS<br/>[FR] L'UTILISATION DE 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES EN TANT QU'INHIBITEURS DE KINASES
申请人:ALLERGAN INC
公开号:WO2003027102A1
公开(公告)日:2003-04-03
The present invention relates to organic of general formula (I), capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
申请人:——
公开号:US20030225152A1
公开(公告)日:2003-12-04
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调制和/或抑制异常细胞增殖。
3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Andrews W. Steven
公开号:US20060025413A1
公开(公告)日:2006-02-02
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调节和/或抑制异常细胞增殖。
3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Allergan, Inc.
公开号:US06765012B2
公开(公告)日:2004-07-20
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调控和/或抑制异常细胞增殖。
3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS